SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
January 12, 2026
 · 
6 min read
Press Releases
Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy
January 12, 2026
 · 
3 min read
Press Releases
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
January 12, 2026
 · 
3 min read
Press Releases
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
January 12, 2026
 · 
5 min read
Press Releases
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
January 12, 2026
 · 
11 min read
Press Releases
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - January 11, 2026
January 12, 2026
 · 
14 min read
Press Releases
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 12, 2026
 · 
5 min read
Press Releases
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
January 12, 2026
 · 
9 min read
Press Releases
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026
January 12, 2026
 · 
19 min read
Press Releases
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
January 12, 2026
 · 
9 min read
Press Releases
Zymeworks Outlines Strategic Priorities and Outlook for 2026
January 12, 2026
 · 
22 min read
Press Releases
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
January 12, 2026
 · 
7 min read
Press Releases
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
January 12, 2026
 · 
6 min read
Press Releases
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
January 12, 2026
 · 
15 min read
Press Releases
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
January 12, 2026
 · 
9 min read
Press Releases
Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
January 12, 2026
 · 
10 min read
Press Releases
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
January 12, 2026
 · 
3 min read
Press Releases
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
 · 
9 min read
Press Releases
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
January 12, 2026
 · 
8 min read
Press Releases
Exagen Inc. Announces Select Preliminary 2025 Financial Results
January 12, 2026
 · 
5 min read
Press Releases
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
 · 
7 min read
Press Releases
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
 · 
6 min read
Press Releases
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
January 12, 2026
 · 
8 min read
Press Releases
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
January 12, 2026
 · 
7 min read
Press Releases
Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
December 18, 2025
 · 
3 min read
Press Releases
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
 · 
1 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 18, 2025
 · 
3 min read
Press Releases
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
December 18, 2025
 · 
6 min read
Press Releases
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
December 18, 2025
 · 
4 min read
Press Releases
Institut du Cancer de Montpellier and TAE Life Sciences Launch AMBER Project to Bring BNCT to France
December 18, 2025
 · 
3 min read
Press Releases
Cofactor Genomics Advances Predictive Cancer Diagnostics With Landmark OncoPrism-NSCLC Study
December 18, 2025
 · 
3 min read
Press Releases
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
December 18, 2025
 · 
5 min read
Press Releases
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
December 18, 2025
 · 
9 min read
Load More